South Wales, July 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "NEXCORE" on June 26. The details about the trademark application no. UK00004407969 published in the journal no. 2026/028 (July 10).
With Barker Brettell LLP as representative, Axonics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 10 : Nerve stimulator apparatus, namely, an implantable electrical stimulation device; implantable electrical stimulation device for sacral neuromodulation; neurostimulation system, including an implantable device, a patient remote control to regulate stimulation parameters for the implantable device featuring pre-installed software that allows for communication between the remote control and the implantable device; system for sacral neurostimulation to treat bladder and bowel disorders, including an implantable device, a patient remote control to regulate stimulation parameters for the implantable device featuring pre-installed software that allows for communication between the remote control and the implantable device; system for sacral neurostimulation to treat bladder and bowel disorders, including an implantable device, implantable leads, a patient remote control to regulate stimulation parameters for the implantable device featuring pre-installed software that allows for communication between the remote control and the implantable device; neurostimulation system, including a rechargeable implantable device, a patient remote control to regulate stimulation parameters for the implantable device featuring pre-installed software that allows for communication between the remote control and the implantable device; system for sacral neurostimulation to treat bladder and bowel disorders, including a rechargeable implantable device, a patient remote control to regulate stimulation parameters for the implantable device featuring pre-installed software that allows for communication between the remote control and the implantable device; system for sacral neurostimulation to treat bladder and bowel disorders, including a rechargeable implantable device, implantable leads, a patient remote control to regulate stimulation parameters for the implantable device featuring pre-installed software that allows for communication between the remote control and the implantable device, and a charging system including a charging device, a power supply, a charging station and a wearable belt.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004407969
Disclaimer: Curated by HT Syndication.
